IGFBP2/FAK pathway is causally associated with dasatinib resistance in non-Small cell lung cancer cells

Haibo Lu, Li Wang, Wen Gao, Jieru Meng, Bingbing Dai, Shuhong Wu, John Minna, Jack A. Roth, Wayne L. Hofstetter, Stephen G. Swisher, Bingliang Fang

Research output: Contribution to journalArticlepeer-review

55 Scopus citations

Fingerprint

Dive into the research topics of 'IGFBP2/FAK pathway is causally associated with dasatinib resistance in non-Small cell lung cancer cells'. Together they form a unique fingerprint.

Medicine & Life Sciences